Pharma & Data Transparency

I absolutely adore those instances when my job and my degree dovetail, so reading about the pharmaceutical industry's latest proposal for more transparent data was quite interesting. The interplay between data transparency to validate the effectiveness of clinical trials and protecting the privacy of the patients involved in those trials is certainly proving to be … Continue reading Pharma & Data Transparency

Public health and drug compounding

From the New York Times, a story of how pharmaceutical compounders have been able to secure less oversight than most pharmaceutical companies. Despite two decades of dire health warnings and threats of federal intervention, the specialty drugmakers at the center of the nation’s deadly meningitisoutbreak have repeatedly staved off tougher federal oversight with the help … Continue reading Public health and drug compounding

Sanofi halves price of cancer drug Zaltrap after Sloan-Kettering rejection

From the New York Times: In an unusual move, a big drug company said on Thursday that it would effectively cut in half the price of a new cancer drug after a leading cancer center said it would not use the drug because it was too expensive. The move — announced by Sanofi for the … Continue reading Sanofi halves price of cancer drug Zaltrap after Sloan-Kettering rejection

India weighs providing free drugs at state-run hospitals

From the New York Times: In what would be a landmark increase in the Indian government’s spending on public health, New Delhi is completing a proposal to provide hundreds of essential drugs free to patients in government-run hospitals and clinics at a cost of nearly $5 billion over five years, officials said Thursday. The proposal, … Continue reading India weighs providing free drugs at state-run hospitals

Medication Safety and Medical Resident Supervision

The February issue of AHRQ Web M&M features a Spotlight Case on e-prescribing when a error was noted and cancelled in teh patient record, but not in the pharmacy. Commentary is provided by Elisa Ashton, PharmD., an assistant clinical professor at the University of California, San Francisco. Perspectives on Safety features an interview with Lawrence Smith, … Continue reading Medication Safety and Medical Resident Supervision

Combination of oral drugs suppresses common type of hepatitis C, according to University of Michigan-led research

Led by University of Michigan researcher Dr. Anna Lok, this study indicates that interferon free treatment for hepatitis C may be possible in the near future. “In this pilot study, patients with hepatitis C genotype 1 infection, who had not responded to previous treatment with PEG-interferon alfa and ribavirin, were given a combination of two … Continue reading Combination of oral drugs suppresses common type of hepatitis C, according to University of Michigan-led research

Epocrates–The App is Free, but Come with Focused Ads

Epocrates, provider of a very popular free phone app that lets clinicians look up information on drug dosing, interactions and insurance coverage while seeing a patient, has a problem:  advertising.  According to an article in the New York Times, "the apps can select messages based on each doctor’s search and prescription histories, and the company has ambitious … Continue reading Epocrates–The App is Free, but Come with Focused Ads

New App–LactMed for iPhone & Android

Need information on maternal and infant drug levels, their possible effects on lactation and breastfed infants, and alternative drugs you should consider?  LactMed can help--and now it's available as a free app! Download the app for iPhones here. Follow the steps to load the app on your Android device here. Find this and other free  apps on our … Continue reading New App–LactMed for iPhone & Android

LactMed Adds Complementary and Alternative Medicine Products

LactMed, the National Library of Medicine's database of drugs and other chemicals to which breastfeeding mothers may be exposed, has added complementary and alternative medicine (CAM) products. LactMed focuses on potential side effects in mothers and infants and on other problems associated with the products. The CAM records, currently 19 with 100 expected, feature a new field for … Continue reading LactMed Adds Complementary and Alternative Medicine Products